Summary

biotechnology, allograft, surgical, medical, scientific, manufacturing, regenerative, medicine, inhalant, injectable, opthalmic

Description

Description

Regenerative Processing Plant is a Federal Food and Drug Administration (FDA) registered tissue processor that produces sterile liquid allograft in eyedrops, and inhalable and injectable form.

Special details

Regenerative Processing Plant is a Federal Food and Drug Administration (FDA) registered tissue processor. RPP has developed the only proprietary patent pending process to sterilize placental derived biomaterials without harsh terminal irradiation thus insuring patient safety while maintaining cell viability and activity. RPP receives gifted birth tissue from living donors collected by an AATB accredited recovery agency. Donors are screened by RPP’s Medical Director for possible contra-indications prior to acceptance and all products are tested before, during and after processing for sterility and absence of bio-burden.

Profile

  • Incorporated in
  • Established since
    2013
  • Main/Branch
    Branch

Address

Contact